Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 45, Issue 9, 2000, Pages 1828-1835

  Sans, M ^a   Fuster, D ^a   Llach, J ^a   Lomena, F ^a   Bordas, J M ^a   Herranz, R ^a   Pique, J M ^a   Panes, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Crohn's disease; Inflammation; Inflammatory bowel disease; Leukocyte; Technetium 99m hexamethyl propylene amine oxime; Ulcerative colitis

Indexed keywords

AMINOSALICYLIC ACID; CORTICOSTEROID; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CELL LABELING; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M EXAMETAZIME;

EID: 0033787630     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005513723968     Document Type: Article

References (19)

1. Indium-111 autologous leucocyte scanning: Comparison with radiology for imaging the colon in inflammatory bowel disease
2. Evaluation of indium scintigraphy in patients with active inflammatory bowel disease
3. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease
4. Value of positive technetium-99m leucocyte scans in predicting intestinal inflammation
5. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label
6. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease
7. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation
8. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease
9. Quantification of disease activity in Crohn's disease by computer analysis of Tc-99m hexamethyl propylene amine oxime (HMPAO) labelled leucocyte images
10. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: Diagnostic and clinical relevance
11. Technetium-99m-HMPAO labelled leucocytes in the detection and monitoring of inflammatory bowel disease in children
12. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes
13. Inflammation: Imaging with Tc-99m HMPAO-labeled leukocytes
14. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease
15. Do technetium-99m hexamethylpropylene amine oxime-labeled leukocytes truly reflect the mucosal inflammation in patients with ulcerative colitis?
16. An index of inflammatory activity in patients with Crohn's disease
17. An index of disease activity in patients with ulcerative colitis
18. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime
19. Measures of differential diagnostic value of diagnostic procedures